Benedikt S Saller

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Nlrp Inflammasome

Top Venues

Science advances

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Ronit Schwartz Wertman, Winslow Yost, Beatrice I Herrmann, Christopher M Bourne, Daniel Sorobetea, Christina K Go, Benedikt S Saller, Olaf Gross, Phillip Scott, Anthony Rongvaux, Cornelius Y Taabazuing, Igor E Brodsky
Distinct sequential death complexes regulate pyroptosis and IL-1β release in response to Yersinia blockade of immune signaling. Science advances 10 (30) (2024)
Ronit Schwartz Wertman, Winslow Yost, Beatrice I Herrmann, Christopher M Bourne, Daniel Sorobetea, Christina K Go, Benedikt S Saller, Olaf Gross, Phillip Scott, Anthony Rongvaux, Cornelius Y Taabazuing, Igor E Brodsky
Distinct sequential death complexes regulate pyroptosis and IL-1β release in response to Yersinia blockade of immune signaling. Science advances 10 (30) (2024)
Ronit Schwartz Wertman, Winslow Yost, Beatrice I Herrmann, Christopher M Bourne, Daniel Sorobetea, Christina K Go, Benedikt S Saller, Olaf Gross, Phillip Scott, Anthony Rongvaux, Cornelius Y Taabazuing, Igor E Brodsky
Distinct sequential death complexes regulate pyroptosis and IL-1β release in response to Yersinia blockade of immune signaling. Science advances 10 (30) (2024)
Ronit Schwartz Wertman, Winslow Yost, Beatrice I Herrmann, Christopher M Bourne, Daniel Sorobetea, Christina K Go, Benedikt S Saller, Olaf Gross, Phillip Scott, Anthony Rongvaux, Cornelius Y Taabazuing, Igor E Brodsky
Distinct sequential death complexes regulate pyroptosis and IL-1β release in response to Yersinia blockade of immune signaling. Science advances 10 (30) (2024)
Emilia Neuwirt, Giovanni Magnani, Tamara Ćiković, Svenja Wöhrle, Larissa Fischer, Anna Kostina, Stephan Flemming, Nora J Fischenich, Benedikt S Saller, Oliver Gorka, Steffen Renner, Claudia Agarinis, Christian N Parker, Andreas Boettcher, Christopher J Farady, Rebecca Kesselring, Christopher Berlin, Rolf Backofen, Marta Rodriguez-Franco, Clemens Kreutz, Marco Prinz, Martina Tholen, Thomas Reinheckel, Thomas Ott, Christina J Groß, Philipp J Jost, Olaf Gross
Tyrosine kinase inhibitors can activate the NLRP3 inflammasome in myeloid cells through lysosomal damage and cell lysis. Science signaling 16 (768) (2023)
Emilia Neuwirt, Giovanni Magnani, Tamara Ćiković, Svenja Wöhrle, Larissa Fischer, Anna Kostina, Stephan Flemming, Nora J Fischenich, Benedikt S Saller, Oliver Gorka, Steffen Renner, Claudia Agarinis, Christian N Parker, Andreas Boettcher, Christopher J Farady, Rebecca Kesselring, Christopher Berlin, Rolf Backofen, Marta Rodriguez-Franco, Clemens Kreutz, Marco Prinz, Martina Tholen, Thomas Reinheckel, Thomas Ott, Christina J Groß, Philipp J Jost, Olaf Gross
Tyrosine kinase inhibitors can activate the NLRP3 inflammasome in myeloid cells through lysosomal damage and cell lysis. Science signaling 16 (768) (2023)
Emilia Neuwirt, Giovanni Magnani, Tamara Ćiković, Svenja Wöhrle, Larissa Fischer, Anna Kostina, Stephan Flemming, Nora J Fischenich, Benedikt S Saller, Oliver Gorka, Steffen Renner, Claudia Agarinis, Christian N Parker, Andreas Boettcher, Christopher J Farady, Rebecca Kesselring, Christopher Berlin, Rolf Backofen, Marta Rodriguez-Franco, Clemens Kreutz, Marco Prinz, Martina Tholen, Thomas Reinheckel, Thomas Ott, Christina J Groß, Philipp J Jost, Olaf Gross
Tyrosine kinase inhibitors can activate the NLRP3 inflammasome in myeloid cells through lysosomal damage and cell lysis. Science signaling 16 (768) (2023)